Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Low Dose Bupivacaine Baricity for TURP
NCT01861041Phase 4Unknown
- Sponsor
- Dışkapı Yıldırım Beyazıt Training and Research Hospital
- Start
- May 2013
- Primary completion
- Jul 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, triple-blind trial of bupivacaine in benign prostatic hyperplasia (BPH) (2 arms), sponsored by Dışkapı Yıldırım Beyazıt Training and Research Hospital. Primary endpoint: Spinal Block Quality. Status: unknown.
02
Drugs
bupivacaine
03
Conditions
benign prostatic hyperplasia (BPH)
Beyond the preview
Go deeper on NCT01861041.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01861041.